Skip to main content
Fig. 1 | BMC Rheumatology

Fig. 1

From: Identification of poor prognostic joint locations in an early rheumatoid arthritis cohort at risk of rapidly progressing disease: a post-hoc analysis of the Phase III AGREE study

Fig. 1

Treatment group comparisons of Boolean remission rates (6 months) in patients with baseline swollen joint status by A large and B small joint location. ABA, abatacept; MTX, methotrexate; MCP metacarpophalangeal joints; MTP, metatarsophalangeal joints. **p < 0.001; ^p < 0.01; *p < 0.05. p-value is based on a continuity-corrected chi-square test. The error bars represent 95% confidence interval

Back to article page

BMC Rheumatology

ISSN: 2520-1026

Contact us